CASI Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 08/14/2025 | 987.26 K | $1.16 M | 0.00% | 6.37% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 08/12/2025 | 787.12 K | $928.80 K | -40.79% | 5.08% |
| WOODLINE PARTNERS LP | 08/14/2025 | 165.64 K | $195.46 K | 0.78% | 1.07% |
| WELLINGTON SHIELDS CAPITAL MANAGEMENT, LLC | 08/05/2025 | 90.85 K | $107.20 K | -0.05% | 0.59% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 44.12 K | $52.06 K | -6.96% | 0.28% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 39.20 K | $46.26 K | 0.77% | 0.25% |
| WELLINGTON SHIELDS & CO., LLC | 08/05/2025 | 30.09 K | $35.51 K | 0.00% | 0.19% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 18.81 K | $22.19 K | -2.87% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 12.06 K | $14.23 K | 18,174.24% | 0.08% |
| TWO SIGMA SECURITIES, LLC | 08/14/2025 | 11.60 K | $13.69 K | 100.00% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 10.15 K | $11.98 K | -51.99% | 0.07% |
| ROYAL BANK OF CANADA | 08/14/2025 | 9.95 K | $11.00 K | 2.58% | 0.06% |
| UBS GROUP AG | 08/14/2025 | 954 | $1.13 K | -69.12% | 0.01% |
| WELLS FARGO & COMPANY/MN | 08/14/2025 | 505 | $596 | 0.00% | 0.00% |
| BLACKROCK, INC. | 08/12/2025 | 296 | $349 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 134 | $158 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2025 | 25 | $30 | 0.00% | 0.00% |
| CITIGROUP INC | 08/11/2025 | 19 | $22 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/13/2025 | 13 | $15 | 0.00% | 0.00% |
| COLONIAL TRUST CO / SC | 08/13/2025 | 11 | $13 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 08/12/2025 | 5 | $6 | 0.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 07/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WEST PACES ADVISORS INC. | 07/23/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CASI Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of CASI Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Wellington Shields Capital Management, LLC: 69,535
Wellington Shields & Co., LLC: 30,091
Ground Swell Capital, LLC: 10,135
VR Adviser, LLC: 987,259
Foresite Capital Management VI LLC: 787,121
Woodline Partners LP: 165,640
14.26% of CASI Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.20 M shares in the last 24 months. This purchase volume represents approximately $3.03 M in transactions.